Wintest
6721
Osaka Yuka Industry
4124
D. Western Therapeutics Institute
4576
Asiro
7378
Hamee
3134
(FY)Mar 31, 2024 | (FY)Mar 31, 2023 | (FY)Mar 31, 2022 | (FY)Mar 31, 2021 | (FY)Mar 31, 2020 | (FY)Mar 31, 2019 | (FY)Mar 31, 2018 | (FY)Mar 31, 2017 | (FY)Mar 31, 2016 | (FY)Mar 31, 2015 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating cash flow (Indirect Method) | ||||||||||
Cash from operating activities | 46.73%8.43B | -27.43%5.75B | -36.46%7.92B | 5.22%12.46B | 7.20%11.84B | -2.25%11.05B | 17.73%11.3B | -4.63%9.6B | 5.80%10.07B | -4.42%9.51B |
Net profit before non-cash adjustment | 329.30%5.02B | -159.77%-2.19B | -41.54%3.66B | 115.63%6.26B | -36.15%2.9B | 16.44%4.55B | -7.68%3.91B | -1.99%4.23B | -26.24%4.32B | 11.74%5.85B |
Total adjustment of non-cash items | -31.94%4.63B | 12.23%6.8B | -12.67%6.06B | -16.76%6.94B | 19.60%8.34B | -0.47%6.97B | 18.36%7B | 0.51%5.92B | 69.63%5.89B | -9.14%3.47B |
-Depreciation and amortization | -14.66%6.19B | 3.94%7.25B | 0.01%6.98B | -3.23%6.98B | -0.93%7.21B | 7.06%7.28B | 7.55%6.8B | 15.45%6.32B | 10.83%5.47B | 14.14%4.94B |
-Reversal of impairment losses recognized in profit and loss | --0 | --363M | --0 | 27.23%299M | --235M | ---- | ---- | ---- | 845.00%189M | -93.63%20M |
-Disposal profit | --0 | ---32M | --0 | --0 | --0 | --0 | --0 | -375.00%-19M | ---4M | --0 |
-Net exchange gains and losses | -62.82%-1.23B | 11.31%-753M | -293.06%-849M | -183.72%-216M | 203.61%258M | -172.59%-249M | 1,219.23%343M | -95.64%26M | 145.43%596M | -98.19%-1.31B |
-Other non-cash items | -1,016.67%-335M | 56.52%-30M | 42.98%-69M | -119.12%-121M | 1,172.88%633M | 57.25%-59M | 66.42%-138M | -11.38%-411M | -108.47%-369M | -136.00%-177M |
Changes in working capital | -207.05%-1.21B | 163.00%1.13B | -143.57%-1.8B | -223.17%-739M | 228.21%600M | -219.69%-468M | 171.22%391M | -294.96%-549M | -172.77%-139M | -78.68%191M |
-Change in receivables | -411.95%-1.63B | -4,442.86%-318M | 65.00%-7M | -101.96%-20M | 6,293.75%1.02B | 100.98%16M | -411.32%-1.63B | -441.94%-318M | -61.25%93M | 342.42%240M |
-Change in inventory | 146.02%393M | -152.66%-854M | 33.98%-338M | -675.76%-512M | 76.34%-66M | -22.91%-279M | 1.73%-227M | -175.00%-231M | 33.86%-84M | -4,333.33%-127M |
-Change in payables | -146.50%-345M | 74,300.00%742M | -101.92%-1M | 108.24%52M | -271.00%-631M | -52.93%369M | 186.13%784M | 29.25%274M | 218.44%212M | -142.42%-179M |
-Provision for loans, leases and other losses | 642.31%282M | 48.51%-52M | -294.23%-101M | 108.00%52M | -52.83%25M | 47.22%53M | -50.68%36M | 114.71%73M | -62.64%34M | -63.75%91M |
-Changes in other current assets | -99.52%6M | 182.67%1.25B | -16,900.00%-1.51B | -92.68%9M | 180.92%123M | -132.00%-152M | 228.03%475M | -319.53%-371M | 203.05%169M | -925.00%-164M |
-Changes in other current liabilities | -78.69%78M | 130.19%366M | 149.69%159M | -353.97%-320M | 126.53%126M | -150.05%-475M | 3,854.17%949M | 104.26%24M | -270.61%-563M | -1.49%330M |
Dividends paid (cash flow from operating activities) | ||||||||||
Dividends received (cash flow from operating activities) | ||||||||||
Interest paid (cash flow from operating activities) | -35.87%-125M | -22.67%-92M | 0.00%-75M | 13.79%-75M | 14.71%-87M | -5.15%-102M | 7.62%-97M | 11.76%-105M | 19.59%-119M | -55.79%-148M |
Interest received (cash flow from operating activities) | 57.23%261M | 25.76%166M | -12.58%132M | 0.00%151M | 3.42%151M | -11.52%146M | 51.38%165M | -0.91%109M | -23.08%110M | 28.83%143M |
Tax refund paid | 59.01%-471M | 45.90%-1.15B | -58.74%-2.12B | 15.26%-1.34B | -8.82%-1.58B | -1.40%-1.45B | 10.79%-1.43B | 28.81%-1.6B | 14.59%-2.25B | -67.07%-2.64B |
Other operating cash inflow (outflow) | 6,875.00%279M | 4M | 0 | -262.36%-729M | 750.72%449M | -6,800.00%-69M | -1M | 0 | 581.16%940M | 885.71%138M |
Operating cash flow | 79.14%8.38B | -20.10%4.68B | -44.12%5.85B | -2.85%10.47B | 12.60%10.78B | -3.68%9.57B | 24.23%9.94B | -8.51%8B | 24.75%8.74B | -16.61%7.01B |
Investing cash flow | ||||||||||
Net PPE purchase and sale | -23.57%-1.95B | 84.85%-1.57B | -166.85%-10.39B | -46.17%-3.89B | 73.57%-2.66B | -29.39%-10.08B | 47.54%-7.79B | -59.06%-14.85B | -28.34%-9.34B | 13.12%-7.28B |
Net business purchase and sale | --0 | ---628M | --0 | ---- | ---- | ---- | ---558M | ---- | ---- | ---- |
Net investment product transactions | 277.53%3.14B | -77.45%-1.77B | -239.46%-998M | -398.31%-294M | -255.26%-59M | 107.28%38M | -1,731.25%-522M | -51.52%32M | -48.03%66M | -84.32%127M |
Net changes in other investments | 12.07%-153M | 20.55%-174M | -52.08%-219M | 16.76%-144M | 33.97%-173M | -66.88%-262M | -22.66%-157M | -56.10%-128M | -36.67%-82M | -15.38%-60M |
Investing cash flow | 125.22%1.05B | 64.27%-4.15B | -167.96%-11.61B | -49.59%-4.33B | 71.90%-2.9B | -14.14%-10.31B | 39.60%-9.03B | -59.81%-14.95B | -29.76%-9.35B | 23.65%-7.21B |
Financing cash flow | ||||||||||
Net issuance payments of debt | -389.00%-7.62B | -44.14%2.64B | 254.03%4.72B | -45.47%-3.07B | -151.10%-2.11B | 27.33%4.12B | -66.14%3.24B | 231.59%9.56B | 11.83%2.88B | -14.43%2.58B |
Net common stock issuance | -29.81%113M | -19.50%161M | 21.21%200M | 119.88%165M | 17.00%-830M | -804.23%-1B | -3.40%142M | -16.48%147M | 18.12%176M | 50.51%149M |
Cash dividends paid | 33.32%-1.27B | -0.05%-1.91B | -0.37%-1.91B | -0.05%-1.9B | 1.45%-1.9B | 0.16%-1.93B | -0.05%-1.93B | -1.85%-1.93B | 0.84%-1.9B | -5.52%-1.91B |
Net other fund-raising expenses | -700.00%-8M | 0.00%-1M | ---1M | ---- | ---- | 50.00%-1M | -100.00%-2M | 0.00%-1M | ---1M | ---- |
Financing cash flow | -1,089.75%-8.79B | -70.52%888M | 162.74%3.01B | 0.74%-4.8B | -505.11%-4.84B | -17.48%1.19B | -81.40%1.45B | 568.30%7.78B | 42.47%1.16B | -37.20%817M |
Net cash flow | ||||||||||
Beginning cash position | 15.85%12.05B | -18.97%10.4B | 12.57%12.83B | 36.87%11.4B | 6.95%8.33B | 42.30%7.79B | 17.45%5.47B | 12.37%4.66B | 18.96%4.15B | 9.38%3.49B |
Current changes in cash | -55.37%632M | 151.58%1.42B | -305.16%-2.75B | -56.06%1.34B | 560.52%3.05B | -80.44%461M | 183.29%2.36B | 49.91%832M | -10.19%555M | 133.21%618M |
Effect of exchange rate changes | 44.59%334M | -25.48%231M | 226.32%310M | 406.45%95M | -183.78%-31M | 184.09%37M | -144.44%-44M | 58.14%-18M | -202.38%-43M | 23.53%42M |
Cash adjustments other than cash changes | 62,400.00%625M | 0.00%1M | --1M | ---- | 32.56%57M | 2,050.00%43M | 300.00%2M | -200.00%-1M | 0.00%1M | --1M |
End cash Position | 13.21%13.64B | 15.85%12.05B | -18.97%10.4B | 12.57%12.83B | 36.87%11.4B | 6.95%8.33B | 42.30%7.79B | 17.45%5.47B | 12.37%4.66B | 18.96%4.15B |
Free cash flow | 98.71%6.16B | 168.16%3.1B | -170.18%-4.55B | -19.57%6.48B | 1,210.62%8.05B | -134.97%-725M | 130.18%2.07B | -1,020.55%-6.87B | -130.45%-613M | -1,366.67%-266M |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |